Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel SR Monotherapy in Major Depressive Disorder (OPAL)
NCT00326144Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of quetiapine in major depressive disorder (MDD), sponsored by AstraZeneca. Started Apr 2006; status: completed.
02
Drugs
quetiapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00326144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00326144.